Table III. —Group scores, between and within group differences for MVIC strength values.
| Secondary outcomes | Baseline | End of treatment 4 weeks | Follow-up 2 months | 4 weeks - baseline | 2 months - baseline | 2 months - 4 weeks |
|---|---|---|---|---|---|---|
| MVIC Knee ext.a, b | ||||||
| Group 1 (N.=30) | 229.1 (212.6, 245.69) |
312.6 (336.69, 424.66) |
380.7 (333.42, 427.93) |
136.1 (103.20, 168.99)* |
151.5 (108.37, 194.70)* |
15.4 (-5.53, 36.45) |
| Group 2 (N.=30) | 249.6 (220.66, 278.61) |
412.9 (367.20, 458.72) |
459.4 (412.13, 506.64) |
163.3 (126.42, 200.23)* |
209.7 (167.84, 251.66)* |
46.4 (23.84, 69.01)* |
| Between groups dif. | 20.4 (-12.16, 53.15) |
47.7 (-8.45, 103.90) |
78.7 (11.88, 145.54)* |
|||
| MVIC Hip ext a, b | ||||||
| Group 1 (N.=30) | 171.9 (151.7, 195.04) |
204.9 (187.04, 222.83) |
211.1 (191.94, 230.17) |
32.9 (22.35, 43.61)* |
39.1 (27.35, 50.84)* |
6.1 (-1.37, 13.61) |
| Group 2 (N.=30) | 215.3 (192.22, 235.56) |
252.2 (234.33, 270.13) |
254.1 (234.95, 273.18) |
36.9 (25.27, 48.58)* |
38.7 (29.27, 48.25)* |
1.8 (-6.34, 10.01) |
| Between groups dif. | -43.3 (-71.99, -14.69)* |
-47.3 (-72.61, -21.98)* |
-43.0 (-70.04, -15.98)* |
|||
| MVIC Hip abd a, b | ||||||
| Group 1 (N.=30) | 114.6 (104.79, 124.52) |
133.4 (121.11, 145.71) |
134.9 (123.88, 146.02) |
18.7 (11.50, 26.01)* |
20.3 (13.39, 27.19)* |
1.5 (-4.76, 7.84) |
| Group 2 (N.=30) | 124.9 (113.44, 136.49) |
147.3 (137.36, 157.35) |
148.7 (137.87, 159.69) |
22.3 (13.91, 30,87)* |
23.8 (15.65, 31.99)* |
1.4 (-4.47, 7.33) |
| Between groups dif. | -10.3 (-25.16, 4.54) |
-13.9 (-29.46, 1.56) |
-13.8 (-29.04, 1.38) |
|||
Values are presented as mean (95% CI). MPFFA: Maximum Pain Free Flexion Angle. aHigh values indicate greater strength; bvalues are in Newtons; *P<0.05.